Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,045,600
-$8,516,400 QoQ
Shares Held
330,000
-63.3% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#73
of 257 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EcoR1 Capital, LLC holds $1,935,887,028 across 29 Biotechnology names. ERAS ranks #25 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
|
22,970,388 | $600,445,942 | |
| 2 | ANAB |
Anaptysbio, Inc
|
7,880,094 | $531,906,345 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,824,469 | $155,492,635 | |
| 4 | CGON |
CG Oncology, Inc.
|
1,494,300 | $106,170,015 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
1,389,276 | $75,771,113 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
6,728,116 | $72,865,496 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
3,174,519 | $63,871,322 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
1,667,119 | $49,980,227 |
All Filings in ERAS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,045,600 | 330,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,562,000 | 900,000 | Shares | Sole | 2026-05-15 | |
| 2023-03-31 | $2,042,107 | 678,441 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,924,080 | 678,441 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,291,839 | 678,441 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,778,916 | 678,441 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,834,592 | 678,441 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,906,000 | 700,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,854,000 | 700,000 | Shares | Sole | 2021-11-22 | |
| No filing history on record for this holder in this stock. | ||||||